Drug Safety Update
December 2015: Bisphosphonates and very rare reports of osteonecrosis of the external auditory canal. See also see BNF for safety guidance.
June 2011: Bisphosphonates and atypical femoral fractures. See also see BNF for safety guidance.
November 2009: Bisphosphonates and osteonecrosis of the jaw. See also see BNF for safety guidance.
An option for osteoporosis only if the patient meets NICE TA464 criteria
|1 pre-filled disposable injection||£65.40|